Parker Institute for Cancer Immunotherapy
Search
Search Close

Early Career Researcher Awards

Investing in Next Generation Talent

We have an ambitious mission. Not only do we invest in the talent of today, we train the cancer immunotherapy leaders of tomorrow. Our financial support, access to cutting-edge technology, impressive network of scientists, and resources empower the next generation of leaders. With PICI, these early career researchers can take bold questions and big ideas and turn them into research that has the potential to transform immunotherapy treatments.

Meet Our Awardees

58

NO. OF AWARDS SINCE 2016

$22M+

TOTAL AMOUNT AWARDED

Early Career Researcher Awards

Since our inception, we’ve been planning for the future. And the brightest young investigators in cancer immunotherapy are the future. In 2016, we launched the Parker Scholars, Parker Bridge Fellows and Parker Senior Fellows to support the most ambitious early career researchers. Risk-taking is required. New thinking is mandatory. We challenge them to explore their boldest ideas to propel the field forward. We equip them with cutting-edge tools and technologies. We give them access to data from clinical trials and pre-published papers. We connect them with leading researchers and their peers in cancer immunotherapy. We do our part so they can focus on advancing their science. The end goal: a future where we don’t have to fear cancer.

Related